BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1016 related articles for article (PubMed ID: 34544449)

  • 21. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis.
    Fu Y; Liu L; Wu H; Zheng Y; Zhan H; Li L
    Mol Cell Biochem; 2024 Mar; 479(3):553-566. PubMed ID: 37120495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel long noncoding RNA, LOC440173, promotes the progression of esophageal squamous cell carcinoma by modulating the miR-30d-5p/HDAC9 axis and the epithelial-mesenchymal transition.
    Wang G; Feng B; Niu Y; Wu J; Yang Y; Shen S; Guo Y; Liang J; Guo W; Dong Z
    Mol Carcinog; 2020 Dec; 59(12):1392-1408. PubMed ID: 33079409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA LOC100133669 promotes cell proliferation in oesophageal squamous cell carcinoma.
    Guan Z; Wang Y; Wang Y; Liu X; Wang Y; Zhang W; Chi X; Dong Y; Liu X; Shao S; Zhan Q
    Cell Prolif; 2020 Apr; 53(4):e12750. PubMed ID: 32130753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
    Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
    J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma.
    Zou J; Zhong X; Zhou X; Xie Q; Zhao Z; Guo X; Duan Y
    Biochem Biophys Res Commun; 2021 Nov; 580():48-55. PubMed ID: 34624569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis.
    Zhihua Z; Weiwei W; Lihua N; Jianying Z; Jiang G
    IUBMB Life; 2019 Oct; 71(10):1492-1502. PubMed ID: 31185143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA BCAR4 aggravated proliferation and migration in esophageal squamous cell carcinoma by negatively regulating p53/p21 signaling pathway.
    Yan S; Xu J; Liu B; Ma L; Feng H; Tan H; Fang C
    Bioengineered; 2021 Dec; 12(1):682-696. PubMed ID: 33602031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
    Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
    J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of transcriptome-wide m6A methylome in intermediate-stage Esophageal squamous cell carcinoma.
    Jia X; Zhang Z; Wei R; Li B; Chen Y; Li J
    Pathol Res Pract; 2022 Sep; 237():154055. PubMed ID: 36007412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation.
    Zhang P; Zhang W; Wang X; Li L; Lin Y; Wu N; Mao R; Lin J; Kang M; Ding C
    Cancer Lett; 2024 Jun; 591():216874. PubMed ID: 38636894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET.
    Chen Z; Lin J; Wu S; Xu C; Chen F; Huang Z
    Exp Cell Res; 2018 Jan; 362(1):90-101. PubMed ID: 29126868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.